本页面由Tiger Trade Technology Pte. Ltd.提供服务

Janux Therapeutics, Inc.

15.19
+0.15001.00%
盘后15.01-0.1797-1.18%18:12 EDT
成交量:62.33万
成交额:941.74万
市值:9.24亿
市盈率:-8.28
高:15.24
开:15.00
低:14.90
收:15.04
52周最高:35.34
52周最低:12.12
股本:6,083.17万
流通股本:4,168.06万
量比:0.77
换手率:1.50%
股息:- -
股息率:- -
每股收益(TTM):-1.8336
每股收益(LYR):-1.8336
净资产收益率:-11.48%
总资产收益率:-9.55%
市净率:0.97
市盈率(LYR):-8.28

数据加载中...

2024/09/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/09

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/08/07

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/07

重要事件披露

Form 8-K - Current report
2024/07/22

重要事件披露

Form 8-K - Current report
2024/06/28

重要事件披露

Form 8-K - Current report
2024/06/05

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/06/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/06/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/06/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities